Ligand Pharmaceuticals (LGND) Free Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | 12.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.75% |
| Dec 31, 2025 | -5.85% |
| Sep 30, 2025 | -21.85% |
| Jun 30, 2025 | 43.36% |
| Mar 31, 2025 | -36.52% |
| Dec 31, 2024 | 2.51% |
| Sep 30, 2024 | 66.13% |
| Jun 30, 2024 | -81.07% |
| Mar 31, 2024 | 20.64% |
| Dec 31, 2023 | 155.58% |
| Sep 30, 2023 | -26.26% |
| Jun 30, 2023 | -26.40% |
| Mar 31, 2023 | 26.10% |
| Dec 31, 2022 | 107.94% |
| Sep 30, 2022 | 87.68% |
| Jun 30, 2022 | 2.96% |
| Mar 31, 2022 | 1.59% |
| Dec 31, 2021 | -6.48% |
| Sep 30, 2021 | -3.67% |
| Jun 30, 2021 | -40.28% |
| Mar 31, 2021 | -44.01% |
| Dec 31, 2020 | -72.11% |
| Sep 30, 2020 | -21.29% |
| Jun 30, 2020 | 32.12% |
| Mar 31, 2020 | -4.14% |
| Dec 31, 2019 | -35.07% |
| Sep 30, 2019 | -32.27% |
| Jun 30, 2019 | -20.34% |
| Mar 31, 2019 | 51.71% |
| Dec 31, 2018 | 33.78% |
| Sep 30, 2018 | 37.52% |
| Jun 30, 2018 | 94.38% |
| Mar 31, 2018 | 100.13% |
| Dec 31, 2017 | 45.02% |
| Sep 30, 2017 | 90.83% |
| Jun 30, 2017 | 36.27% |
| Mar 31, 2017 | 95.25% |
| Dec 31, 2016 | 12.29% |
| Sep 30, 2016 | 221.63% |
| Jun 30, 2016 | 11.18% |
| Mar 31, 2016 | 84.78% |
| Dec 31, 2015 | 101.59% |
| Sep 30, 2015 | 136.32% |
| Jun 30, 2015 | 146.31% |
| Mar 31, 2015 | 178.22% |
| Dec 31, 2014 | 12.76% |
| Sep 30, 2014 | 73.27% |
| Jun 30, 2014 | 35.98% |
| Mar 31, 2014 | 41.58% |
| Dec 31, 2013 | 138.01% |
| Sep 30, 2013 | 56.66% |